| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vertex Pharmaceuticals Incorporated (VRTX) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 69 sells. VRTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 133.5K | $60.29M | - | |
| COO | 63.4K | $28.62M | - | |
| VP | 51.1K | $23.07M | - | |
| VP | 42.3K | $19.10M | - | |
| Other | 24.0K | $10.85M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 29, 2020 | Parini Michael | EVP, Chief Adm, Leg &Bd Off | Sale+OE | 2,125 | $254.95 | $541,769.30 | -1.3% | |
| Apr 28, 2020 | Lee Yuchun | Director | Sale+OE | 1,125 | $257.88 | $290,115.40 | -6.5% | |
| Apr 27, 2020 | Lee Yuchun | Director | Sale+OE | 4,000 | $269.68 | $1,078,704.86 | -15.2% | |
| Apr 23, 2020 | Lee Yuchun | Director | Sale+OE | 4,000 | $270.20 | $1,080,805.22 | -10.2% | |
| Apr 21, 2020 | Lee Yuchun | Director | Sale+OE | 4,000 | $269.96 | $1,079,832.95 | -12.0% | |
| Apr 13, 2020 | Silva Paul M | SVP &Controller | Sale+OE | 859 | $248.72 | $213,649.63 | -0.9% | |
| Apr 6, 2020 | Silva Paul M | SVP &Controller | Sale+OE | 4,891 | $255.57 | $1,249,992.87 | -24.7% | |
| Feb 25, 2020 | Parini Michael | EVP, Cl&Ao | Sell | 1,440 | $236.28 | $340,240.00 | -1.7% | |
| Feb 25, 2020 | Sachdev Amit | EVP, Chief Patient Officer | Sell | 3,376 | $233.53 | $788,401.88 | -1.2% | |
| Feb 25, 2020 | Leiden Jeffrey M47 | CEO &President | Sell | 6,107 | $235.69 | $1,439,382.42 | -1.3% |